Stockreport

MeiraGTx: Bota-Vec Program Advancing With Milestones Being Met [Seeking Alpha]

MeiraGTx Holdings plc - Ordinary Shares  (MGTX) 
PDF Enrollment completed in ongoing phase 3 LUMEOS study, using bota-vec for the treatment of patients with XLRP; Potential results could be released end of 2024 or in earl [Read more]